戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  pigmentosum subunit B/excision repair cross-complementing 3.
2 to have a positive antinuclear antibody, low complement 3, abnormal cytokines, and elevated ferritin
3 on 1) memory, 2) neuroinflammation including complement, 3) AD pathology markers, 4) synaptic markers
4 fied and characterized a novel member of the complement 3/alpha(2)-macroglobulin (C3/alpha(2)M) famil
5 h IGF-1/BP-3 attenuated increases in type I (complement 3, alpha1-acidglycoprotein) and type II (hapt
6    Administration of IL-22 increases hepatic complement 3 and complement deposition on bacteria and i
7 globulin (C3/alpha(2)M) family named CPAMD8 (complement 3 and pregnancy zone protein-like, alpha2-mac
8 ter, but substantially lower activity on the complement 3 and pS2 promoters.
9                                  Variants in complement 3 (C3) and an HLA locus containing both facto
10    In the present study, cerebrospinal fluid complement 3 (C3) and factor H (FH) were measured and ev
11             Specifically, we have identified Complement 3 (C3) as a gene of interest because it is th
12 F was functionally relevant since it reduced complement 3 (C3) deposition by 40%, and this was inhibi
13                                              Complement 3 (C3) glomerulopathy is a rare autoimmune di
14  Primary membranoproliferative GN, including complement 3 (C3) glomerulopathy, is a rare, untreatable
15 al detachments (PEDs) in a woman affected by Complement 3 (C3) glomerulopathy, which represents a spe
16 e levels of interleukin 1beta (IL-1beta) and complement 3 (C3) in glial cells in the acute MPTP mouse
17 CR2) (which recognizes nanosurface-deposited complement 3 (C3)) and complement receptor 1 (CR1) (whic
18 lly validated for four epitopes derived from complement 3, collagen II, thymosin beta4, and gelsolin.
19 escence analyses showed immunoglobulin G and complement 3 component deposits along the BMZ in a linea
20  nonstimulated QFT-GIT supernatants were the complement-3 components C3b, iC3b, and C3d, which were u
21 ained anti-inflammatory effect by inhibiting complement 3 convertase, thereby reducing neutrophil rec
22 complement pathway with isolated or dominant complement 3 deposition in glomeruli.
23 I::kan mutant of R. sphaeroides on a plasmid complemented 3-hydroxypropionate-dependent growth.
24 eas such associations were fully mediated by Complement 3 in AB+ participants.
25  in 2 depend on anomeric configuration, thus complementing (3)J(C1,H3ax/eq) behavior, (b) J(CH) and J
26 nt (ERE) and the human pS2, lactoferrin, and complement 3 physiological target gene promoters.
27 coding a large precursor polyprotein (P3) to complement 3D polymerase and/or precursor polypeptide fu
28 oproteins A-I and A-IV, serum amyloid A, and complement 3 protein (in apolipoprotein B-depleted plasm
29   We determined the efficacy and safety of a complement 3-targeted therapeutic, AMY-101, which was lo